Fox Run Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$825K Buy
+4,271
New +$528K 0.1% 394
2025
Q4
– Sell
-15,623
Closed -$440K – 1274
2025
Q3
$440K Buy
+15,623
New +$473K 0.07% 545
2025
Q2
– Sell
-13,295
Closed -$522K – 1246
2025
Q1
$522K Sell
13,295
-3,444
-21% -$155K 0.08% 473
2024
Q4
$778K Buy
16,739
+6,138
+58% +$277K 0.14% 260
2024
Q3
$479K Buy
10,601
+812
+8% +$38.6K 0.11% 372
2024
Q2
$482K Buy
9,789
+522
+6% +$21.3K 0.09% 425
2024
Q1
$318K Buy
+9,267
New +$334K 0.07% 521
2023
Q4
– Sell
-22,255
Closed -$451K – 1028
2023
Q3
$451K Buy
+22,255
New +$489K 0.13% 295
2023
Q2
– Sell
-30,640
Closed -$462K – 970
2023
Q1
$462K Buy
+30,640
New +$677K 0.15% 247
2022
Q1
– Sell
-3,626
Closed -$281K – 706
2021
Q4
$281K Buy
+3,626
New +$372K 0.17% 250

Other funds holding TWST

Fox Run Management's TWST Position: Q3 2026 in Review

Fox Run Management opened a new position in Twist Bioscience (TWST) in Q3 2026: 4,271 shares worth $825K. The stake represents 0.1% of the portfolio and ranks #394 among its holdings. This is a return to the name: Fox Run Management previously reported a position in TWST as recently as Q3 2025.

Fox Run Management first reported a position in TWST in Q4 2021 and has held it in 10 quarters since. 330 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • Fox Run Management held 4,271 shares of Twist Bioscience worth $825K as of Q3 2026.
  • Twist Bioscience was a new Fox Run Management position in Q3 2026.
  • Twist Bioscience made up 0.1% of Fox Run Management's portfolio in Q3 2026, its #394 holding.
  • Fox Run Management first reported a position in Twist Bioscience in Q4 2021 and has held it in 10 quarters since.
  • 330 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.